FEBRUARY 14-17, 2017

- Venue -
Bombay Convention & Exhibition Centre, Goregaon (East), Mumbai, India

The Rs 25,000 crore (USD 5 million) Indian Pharma Industry is rapidly restructuring the post – 2005 product patent regime. It is a net exporter with about 8 per cent market share (in terms of volume) of the USD 340 billion global market with having seen an average growth of 9 per cent over the last 5 years. Biotechnology is a sunrise industry, expected to vastly improve the quality of life. With more than 800 biotech companies already, the Indian Biotech Industry is getting organised with biotech parks coming up backed by Central and State Government support.

As biopharmaceuticals becoming core of the pharmaceutical industry with significant transformation in the laboratory and in strategy, technology and operations, ChemTech is organizing an International event resonating the ethos of ‘Make in India’ Campaign.

The Indian biopharmaceutical industry is receiving increased global attention owing to low cost, high-quality production and regulatory compliance. The industry provides better manufacturing services as it has good infrastructure for producing biopharmaceuticals in line with the global standards.

India now possess all the ingredients to become a global leader in Biopharmaceutical arena. Advantages in terms of R&D facilities, knowledge, skills, and cost effectiveness, and supported by other factors like; rise in income, enhanced medical infrastructure, rise in the prevalence and treatment of chronic diseases, greater health insurance coverage, more drugs going off patent, launches of patented products, and new market creation in existing white spaces has spurred the growth pace and this is the right time to reap the fruits.

BioPharma World Expo 2017, a well-timed event by ChemTech, will be a perfect destination for Bioprocess Solution Providers, CROs/CMOs, Clinical Trial Supply Chain Providers, Cold Chain Packaging & Cargo, Global Pharma, Regulatory Consultants, Analytical Instrument Manufacturers, Local Biotechs & Start-ups, Quality Control Consultants, Academics, and Regulators to showcase and promote their product and services as well as offer unique opportunity to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in India.

The concurrent conference tracks will explore areas like biosimilars and vaccines development, antibodies, orphan drugs, stem cells, innovations in biologics manufacturing and regulatory compliance; growing issues in generic drug manufacturing and more.